← Back to Search

Digital Messaging Interventions for Physical Activity Promotion (TRY AIM Trial)

N/A

Recruiting

Led By David E Conroy, PhD

Research Sponsored by Penn State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from 12 months to 18 months

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a messaging algorithm to see if it helps young adults become more active & slow weight gain. Participants will wear activity trackers & get messages with activities, quotes, or reminders. Researchers will compare the effects of the algorithm to random messages & no messages.

Who is the study for?

This trial is for young adults with a sedentary lifestyle who own a smartphone, are willing to wear an activity tracker almost all day for 12 months, and can read and understand English. It's not for those living outside the continental US, pregnant or planning pregnancy within a year, diagnosed with certain diseases, involved in other related studies, meeting current physical activity guidelines or unable to do moderate exercise.

What is being tested?

The study tests if personalized text messages based on an algorithm (Precision AIM) increase physical activity more than random messages (Random AIM) or no motivational texts at all (No AIM). Participants will use an activity tracker and receive different types of messages over a year to see which method is most effective in promoting physical activity.

What are the potential side effects?

Since this trial involves education and motivational messaging rather than medication or invasive procedures, there are minimal expected side effects. However, increased physical activity may lead to typical exercise-related discomforts such as muscle soreness.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from 12 months to 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from 12 months to 18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from 12 months to 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Average daily step counts (6 months)

Secondary study objectives

Average daily step counts (12 months)

Average daily step counts (18 months)

Light intensity physical activity duration (12 months)

+11 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Precision AIMExperimental Treatment3 Interventions

Education + activity monitor + up to 4 text messages/day, each drawn from one of 3 content libraries and timed based on a person- and context-specific algorithm that will be updated monthly based on incoming data (within a participant-defined availability window)

Group II: No AIMActive Control2 Interventions

Education + activity monitor

Group III: Random AIMActive Control3 Interventions

Education + activity monitor + up to 4 text messages/day, each drawn from one of 3 content libraries and timed at random (within a participant-defined availability window).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Education

2017

N/A

~4790

Activity tracker

2018

N/A

~230